GlaxoSmithKline announces Q4 2010 legal charge
18 January 2011 | By GlaxoSmithKline (GSK)
GSK expects to record a legal charge for the fourth quarter of 2010 of £2.2 billion ($3.4 billion)...
List view / Grid view
News
Changes to the Roche Corporate Executive Committee
17 January 2011 | By Roche
Erich Hunziker, Chief Financial Officer, Chief Information Officer and Deputy Head of the Corporate Executive Committee has decided to retire from Roche at the end of March 2011...
Domain Therapeutics and Merck Serono announce an agreement to develop drugs for Parkinson’s disease
17 January 2011 | By Andrew Lloyd & Associates
Agreement covers metabotropic glutamate receptor 4 (mGluR4) Positive Allosteric Modulator (PAM) drugs targeting Parkinson's disease...
Molecular Profiles expands offering with new manufacturing capabilities
17 January 2011 | By The Scott Partnership
Expansion enables them to handle larger projects from preformulation through to Phase IIa...
Dr Eric Gluck to present benefits of Thermo Scientific B.R.A.H.M.S procalcitonin (PCT) assay
Thermo Fisher Scientific Inc., the world leader in serving science, today announced that Dr Eric Gluck will host a scientific presentation highlighting the benefits of the Thermo Scientific B.R.A.H.M.S procalcitonin (PCT) assay at the Society of Critical Care Medicine (SCCM) 40th Critical Care Conference 2011.
Seeing is believing – 3D scanning with Tecan’s Infinite® M1000
13 January 2011 | By KDM Communications
Scientists at the Center for CIPSM, have taken advantage of the 3D scanning capabilities of the premium Quad4 Monochromators™-based Infinite M1000 microplate reader...
U.S. Food and Drug Administration (FDA) votes to recommend non-approval of liprotamase
12 January 2011 | By Eli Lilly and Company
Eli Lilly announces that the FDA Gastrointestinal Drugs Advisory Committee has recommended that additional studies be conducted...
Prism Ideas appoints Carol Hills as Chief Operations Officer
11 January 2011 | By The Scott Partnership
Prism Ideas, announced that the company has appointed Carol Hills as chief operations officer (COO) following a successful two-year period as the company's director of medical marketing...
Lilly and Boehringer Ingelheim announce strategic diabetes treatments alliance
11 January 2011 | By Eli Lilly and Company
Global agreement will lead to joint development of diabetes compounds currently in mid- and late-stage development...
Thermo Fisher Scientific to showcase unique ability to assess sepsis risk
Thermo Fisher Scientific Inc., the world leader in serving science, today announced that it will showcase its clinical assay for Procalcitonin (PCT), which aids in the risk assessment of critically ill patients with sepsis, at the Society of Critical Care Medicine (SCCM) 40th Critical Care Conference 2011.
Lallemand Pharma and GlaxoSmithKline partner to launch ISMIGEN in Poland
7 January 2011 | By Lallemand Pharma Europe
Lallemand Pharma Europe and GlaxoSmithKline announced the launch of ISMIGEN® in Poland...
Novozymes Biopharma presents recombinant human albumin research at PepTalk 2011
6 January 2011 | By The Scott Partnership
Novozymes Biopharma is presenting two scientific posters on the manufacturing and use of recombinant albumin in formulation...
Lab21 acquires Microgen Bioproducts
6 January 2011 | By College Hill Ltd
Lab21 Limited, today announced that it has acquired Microgen Bioproducts Ltd a UK company specialising in the development, manufacture and sale of diagnostic tests...
Bicycle Therapeutics appoints Andy Sandham as non-executive Chairman
6 January 2011 | By College Hill Ltd
Bicycle Therapeutics today announced the appointment of Andy Sandham as non-executive Chairman. Andy brings over 30 years experience in building biotechnology businesses...
Avoid Costly Issues within Clinical Trials by Investing in proven Retention and Compliance Solutions, advises Exco InTouch
5 January 2011 | By The Scott Partnership
Increasing trial complexity and duration of studies, patient non-compliance is a growing issue...
